» Articles » PMID: 11104792

Lack of Angiotensin II-facilitated Erythropoiesis Causes Anemia in Angiotensin-converting Enzyme-deficient Mice

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2000 Dec 6
PMID 11104792
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

While nephrologists often observe reduced hematocrit associated with inhibitors of angiotensin-converting enzyme (ACE), the basis for this effect is not well understood. We now report that two strains of ACE knockout mice have a normocytic anemia associated with elevated plasma erythropoietin levels. (51)Cr labeling of red cells showed that the knockout mice have a normal total blood volume but a reduced red cell mass. ACE knockout mice, which lack tissue ACE, are anemic despite having normal renal function. These mice have increased plasma levels of the peptide acetyl-SDKP, a possible stem cell suppressor. However, they also show low plasma levels of angiotensin II. Infusion of angiotensin II for 2 weeks increased hematocrit to near normal levels. These data suggest that angiotensin II facilitates erythropoiesis, a conclusion with implications for the management of chronically ill patients on inhibitors of the renin-angiotensin system.

Citing Articles

The Prognostic Role of RDW in Hospitalized Heart Failure Patients with and Without Chronic Kidney Disease.

Giamouzis G, Kourek C, Magouliotis D, Briasoulis A, Zakynthinos G, Sawafta A J Clin Med. 2024; 13(23).

PMID: 39685852 PMC: 11642004. DOI: 10.3390/jcm13237395.


Cholecystokinin B receptor agonists alleviates anterograde amnesia in cholecystokinin-deficient and aged Alzheimer's disease mice.

Zhang N, Sui Y, Jendrichovsky P, Feng H, Shi H, Zhang X Alzheimers Res Ther. 2024; 16(1):109.

PMID: 38750512 PMC: 11094875. DOI: 10.1186/s13195-024-01472-1.


Hypertension Increases Susceptibility to Experimental Malaria in Mice.

Kandalgaonkar M, Yeoh B, Joe B, Schmidt N, Vijay-Kumar M, Saha P Function (Oxf). 2024; 5(3):zqae009.

PMID: 38706961 PMC: 11065114. DOI: 10.1093/function/zqae009.


Genetic Variations Related to Angiotensin II Production and Risk for Basal Cell Carcinoma.

Gintoni I, Mastrogeorgiou M, Papakosta V, Vassiliou S, Yapijakis C Biochem Genet. 2024; .

PMID: 38546913 DOI: 10.1007/s10528-024-10746-0.


Incorporating inflammatory biomarkers into a prognostic risk score in patients with non-ischemic heart failure: a machine learning approach.

Feng J, Zhao X, Huang B, Huang L, Wu Y, Wang J Front Immunol. 2023; 14:1228018.

PMID: 37649485 PMC: 10463734. DOI: 10.3389/fimmu.2023.1228018.


References
1.
Griffing G, MELBY J . Enalapril (MK-421) and the white cell count and haematocrit. Lancet. 1982; 1(8285):1361. DOI: 10.1016/s0140-6736(82)92430-8. View

2.
Chew C, Weise M, Disney A . The effect of angiotensin II receptor antagonist on the exogenous erythropoietin requirement of haemodialysis patients. Nephrol Dial Transplant. 1999; 14(8):2047-9. View

3.
Lenfant M, Wdzieczak-Bakala J, Guittet E, Prome J, Sotty D, FRINDEL E . Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc Natl Acad Sci U S A. 1989; 86(3):779-82. PMC: 286560. DOI: 10.1073/pnas.86.3.779. View

4.
Seferynska I, Brookins J, Rice J, Fisher J . Erythropoietin production in exhypoxic polycythemic mice. Am J Physiol. 1989; 256(4 Pt 1):C925-9. DOI: 10.1152/ajpcell.1989.256.4.C925. View

5.
Pradelles P, Frobert Y, Creminon C, Liozon E, Masse A, FRINDEL E . Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassay. Biochem Biophys Res Commun. 1990; 170(3):986-93. DOI: 10.1016/0006-291x(90)90489-a. View